These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7597281)

  • 1. [PAS-positive T-lymphocytes in chagasic cardiomyoneuropathy. II. Experimental studies and in cardiopathy].
    Cabral HR
    Rev Fac Cien Med Univ Nac Cordoba; 1994; 52(1):31-3. PubMed ID: 7597281
    [No Abstract]   [Full Text] [Related]  

  • 2. [PAS-positive T-lymphocytes in chagasic cardiomyoneuropathy. I. Immunopathologic mechanisms in Chagas].
    Cabral HR
    Rev Fac Cien Med Univ Nac Cordoba; 1993; 51(2):27-9. PubMed ID: 7784695
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gangliosides in vitro effects on lymphocytes from patients with chronic Chagas disease stimulated with mitogens or heart or brain antigens].
    Cabral HR; Novak IT
    Rev Fac Cien Med Univ Nac Cordoba; 2003; 60(1):19-24. PubMed ID: 16724438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides in chagas' heart disease: a potential treatment for a disease without treatment.
    Bestetti RB
    Cardiology; 1997; 88(3):305-7. PubMed ID: 9129855
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of chronic chagasic cardioneuropathy with a mixture of gangliosides: effect on evolution of circulating antiGM1 antibodies.
    Mitelman J; Gimenez L; Aparicio NJ; Cortelezzi M
    J Cardiol; 1999 Oct; 34(4):189-97. PubMed ID: 10553535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon gamma production by PAS-positive T lymphocytes of chagasic patients infiltrated into human hearts in the sites of lesions.
    Cabral HR; Novak IT; Glocker TM; Castro Viera G
    Rev Fac Cien Med Univ Nac Cordoba; 2006; 63(3):47-52. PubMed ID: 17639817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rethinking the pathogenesis of chronic chagasic cardiopathy at the closing of the millennium].
    Cunha Neto E
    Medicina (B Aires); 1999; 59(5 Pt 1):496-500. PubMed ID: 10684174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gangliosides in neurological pharmacotherapy].
    Małecki A; Małecka E; Trzeciak HI
    Neurol Neurochir Pol; 1992; 26(5):695-701. PubMed ID: 1291908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of acute Chagas cardiopathy in an infant with a suspected transfusion infection].
    Gónzalez-Zambrano H; Amador Mena JE; Delgadillo Jaime CB
    Arch Inst Cardiol Mex; 1999; 69(4):363-6. PubMed ID: 10553194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ganglioside research. Pharmacologic basis and therapeutic aspects of the treatment of polyneuropathy. Satellite symposium of the 61st annual meeting of the German Society for Neurology. 21 September 1988].
    Internist (Berl); 1989 Feb; 30(2 Suppl [G Anniv No GLIOS):1-12. PubMed ID: 2636573
    [No Abstract]   [Full Text] [Related]  

  • 11. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins.
    Mocchetti I
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2283-94. PubMed ID: 16158191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of cardiac arrhythmia refractory to medication in a patient with chronic chagasic cardiopathy].
    Blandón R; De León LE; González B
    Rev Med Panama; 1986 Sep; 11(3):164-70. PubMed ID: 3809620
    [No Abstract]   [Full Text] [Related]  

  • 13. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.
    Maçao LB; Wilhelm Filho D; Pedrosa RC; Pereira A; Backes P; Torres MA; Fröde TS
    Int J Cardiol; 2007 Dec; 123(1):43-9. PubMed ID: 17328977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy].
    Gallerano RR; Sosa RR
    Rev Fac Cien Med Univ Nac Cordoba; 2000; 57(2):135-62. PubMed ID: 12934232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Patients suffering dilated chagasic cardiopathy or non chagasic cardiopathy show an increased levels of tumor necrosis factor alpha].
    D'Angelo-Mendoza E; Rodríguez-Bonfante C; Camacho I; Martínez J; Perdomo T; Cabrera A; Bonfante-Cabarcas R
    Invest Clin; 2005 Sep; 46(3):229-40. PubMed ID: 16152779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic protein from central nervous system myelin.
    Hashim GA
    Prog Clin Biol Res; 1980; 49():79-122. PubMed ID: 6163164
    [No Abstract]   [Full Text] [Related]  

  • 17. [New method of qualitative & quantitative analysis with para-aminosalicylic acid (PAS) & its calcium, potassium & sodium salts].
    TIMMERMANN E
    Sem Med; 1958 Aug; 113(7):332-3. PubMed ID: 13602901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical, parasitological and histopathologic follow-up studies of acute Chagas patients treated with benznidazole].
    Inglessis I; Carrasco HA; Añez N; Fuenmayor C; Parada H; Pacheco JA; Carrasco HR
    Arch Inst Cardiol Mex; 1998; 68(5):405-10. PubMed ID: 10365237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nerve growth factors].
    Vainiene M; Członkowska A
    Neurol Neurochir Pol; 1988; 22(5):444-9. PubMed ID: 3074269
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous spectrophotometric determination of PAS and its degradation product m-aminophenol.
    Vetuschi C; Ragno G
    Pharm Acta Helv; 1988; 63(11):290-3. PubMed ID: 3237720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.